BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15685032)

  • 21. Colorectal carcinoma in young patients: CT detection of an atypical pattern of recurrence.
    Earls JP; Colon-Negron E; Dachman AH
    Abdom Imaging; 1994; 19(5):441-5. PubMed ID: 7950823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.
    Hughes K; Pinsky CM; Petrelli NJ; Moffat FL; Patt YZ; Hammershaimb L; Goldenberg DM
    Ann Surg; 1997 Nov; 226(5):621-31. PubMed ID: 9389396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
    Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The utility of surveillance CT scans in a cohort of survivors of colorectal cancer.
    Braden J; Blinman P; Malalasekera A; Kerin-Ayres K; Spencer J; Southi N; Vardy JL
    J Cancer Surviv; 2023 Aug; 17(4):1202-1210. PubMed ID: 35040075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
    J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
    Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
    Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine preoperative chest computed tomography does not influence therapeutic strategy in patients with colorectal cancer.
    Restivo A; Zorcolo L; Piga S; Cocco IM; Casula G
    Colorectal Dis; 2012 May; 14(5):e216-21. PubMed ID: 22469479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
    Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
    Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
    Makis W; Kurzencwyg D; Hickeson M
    Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
    Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yield of routine imaging after curative colorectal cancer treatment.
    Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F
    Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and timing of recurrence during postoperative surveillance after curative resection for lung adenocarcinoma.
    Koike T; Goto T; Kitahara A; Sato S; Saitoh M; Hashimoto T; Namura O; Takahashi M; Toyabe SI; Tsuchida M
    Surg Today; 2017 Dec; 47(12):1469-1475. PubMed ID: 28474203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up.
    Child PW; Yan TD; Perera DS; Morris DL
    Dis Colon Rectum; 2005 Apr; 48(4):744-8. PubMed ID: 15747072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computed tomography in recurrent or metastatic colon cancer: relation to rising serum carcinoembryonic antigen.
    Shirkhoda A; Staab EV; Bunce LA; Herbst CA; McCartney WH
    J Comput Assist Tomogr; 1984 Aug; 8(4):704-8. PubMed ID: 6736371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
    Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
    Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor surveillance after resection of colorectal cancer].
    Vorburger SA; Gloor B; Candinas D
    Ther Umsch; 2008 Jun; 65(6):329-34. PubMed ID: 18622956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.